Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone in recent-onset psychotic disorder
NCT02949232Phase 4Terminated
- Start
- Jul 2014
- Primary completion
- May 2019
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 4 trial of prednisolone in schizophrenia, schizoaffective disorder, schizophreniform disorder, psychotic disorder. Started Jul 2014; status: terminated.
02
Drugs
prednisolone
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorderpsychotic disorder
Beyond the preview
Go deeper on NCT02949232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02949232.